Results 281 to 290 of about 34,307 (290)

Stapled SC34EK fusion inhibitors with high potency against HIV-1 and improved protease resistance

Chinese Chemical Letters, 2018
Ye Guo, Xuanling Shi
exaly  

HIV fusion inhibitors.

Journal of HIV therapy, 2002
openaire   +1 more source

Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library

Bioorganic and Medicinal Chemistry Letters, 2012
Landon R Whitby, Lifeng Cai, Miriam Gochin   +2 more
exaly  

Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. Integrase inhibition

Biochemical and Biophysical Research Communications, 2007
Sylvia Lee-Huang, Philip Lin Huang, Young-Tae Chang   +2 more
exaly  

Characterization of siamycin I, an HIV fusion inhibitor

Antiviral Research, 1995
P.-F. Lin, H. Samanta, C.M. Bechtold, C. Deminie, M. Alam, K. Riccardi, R.E. Rose, A.K. Patick, R. White, R.J. Colonno   +9 more
openaire   +1 more source

Small molecule fusion inhibitors: Design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41

Bioorganic and Medicinal Chemistry, 2013
Xiaoyang He, Lu Lu, Jiayin Qiu
exaly  

Research Strategy for Short-peptide Fusion Inhibitors Based on 6-HB Core Structure against HIV-1: A Review

Current Pharmaceutical Biotechnology
Guodong Liang
exaly  

Fusion inhibitors securing a future in HIV infection

Inpharma Weekly, 2001
openaire   +1 more source

Multimerised HIV fusion inhibitors

2005
openaire   +1 more source

First fusion inhibitor for advanced HIV.

The American journal of nursing, 2003
openaire   +1 more source